| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/02/2023 | Axsome Therapeutics, Inc. | AXSM | Grant | Restricted Stock Units | 62.4k | $0.00 | $0 | | 03/02/2023 |
| 03/02/2023 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 110k | $65.32 | $7.2M | | 03/02/2023 |
| 03/04/2022 | Axsome Therapeutics, Inc. | AXSM | Grant | Restricted Stock Units | 110.9k | $0.00 | $0 | | 03/04/2022 |
| 03/04/2022 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 209.7k | $29.91 | $6.3M | | 03/04/2022 |
| 03/05/2021 | Axsome Therapeutics, Inc. | AXSM | Grant | Restricted Stock Units | 51.7k | $0.00 | $0 | | 03/05/2021 |
| 03/05/2021 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 97.2k | $65.02 | $6.3M | | 03/05/2021 |
| 03/17/2020 | Axsome Therapeutics, Inc. | AXSM | Grant | Restricted Stock Units | 51.7k | $0.00 | $0 | | 03/17/2020 |
| 03/17/2020 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 168.8k | $45.14 | $7.6M | | 03/17/2020 |
| 10/10/2019 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 68.8k | $17.61 | $1.2M | | 10/10/2019 |
| 03/19/2019 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 319.2k | $12.95 | $4.1M | | 03/19/2019 |
| 03/12/2018 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 187.6k | $2.85 | $534.7k | | 03/12/2018 |
| 03/15/2017 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 149k | $4.95 | $737.6k | | 03/15/2017 |
| 05/27/2016 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 524k | $8.02 | $4.2M | | 05/27/2016 |
| 11/24/2015 | Axsome Therapeutics, Inc. | AXSM | Conversion | Common Stock | 7.2k | $5.94 | $42.9k | | 11/24/2015 |
| 11/24/2015 | Axsome Therapeutics, Inc. | AXSM | Grant | 8% Convertible Note | 7.2k | $5.94 | $42.9k | | 11/24/2015 |